Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Additional registration fee required

Faculty have requested this content not be shared on social media

CME Credit Offered

Poster Icons

Foundation Awardee

No Social Media

Back

Q&A

Clinical Obstetrics

Poster Session 4

(1111) The Effect of Pregnancy Complications on Quality of Life with Placenta Accreta Spectrum

Wednesday, February 14, 2024

1:00 PM – 2:30 PM

Location: Prince George's Exhibit Hall CDE, Lower Atrium Level

Primary & Presenting Author(s)

Kripa Philip, BA

Clinical Research Assistant I
Beth Israel Deaconess Medical Center
Boston, MA, United States

Coauthor(s)

Uma Deshmukh, MD

Maternal-Fetal Medicine Fellow
Beth Israel Deaconess Medical Center
Boston, MA, United States
Bridget M. Donovan, MD (she/her/hers)

MFM Fellow
Beth Israel Deaconess Medical Center
Brookline, MA, United States
GA

Guadalupe Arambula, BS

Beth Israel Deaconess Medical Center
Boston, MA, United States
Helena C. Bartels, MD

Placenta Accreta Clinical Research Fellow
National Maternity Hospital, Dublin, Ireland; UCD School of Medicine, National Maternity Hospital, Dublin, Ireland
Dublin, Ireland, Ireland
DB

Donal Brennan, MD

National Maternity Hospital, Dublin, Ireland; UCD School of Medicine, National Maternity Hospital, Dublin, Ireland
Dubllin, Ireland, Ireland
KT

Kristen Terlizzi, N/A

National Accreta Foundation
Saratoga, CA, United States
BE

Brianna Evans, N/A

National Accreta Foundation
Saratoga, CA, United States
NC

Naomi Cooney, N/A

Placenta Accreta Ireland
Dublin, Ireland, Ireland
Scott A. Shainker, DO, MS (he/him/his)

Director, New England Center for Placental Disorders / Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, MA, United States
Anna M. Modest, MPH, PhD

Faculty Scientist
Beth Israel Deaconess Medical Center
Boston, MA, United States

Objective: Placenta accreta spectrum (PAS) is associated with significant pregnancy and postpartum complications. We evaluated the effect of pregnancy complications during a PAS pregnancy on quality of life (QOL).

Study Design: This was a retrospective survey from February-May 2023 of patients with a PAS pregnancy enrolled in the National Accreta Foundation or Placenta Accreta Ireland. QOL was assessed using the validated SF-36 Short Form measuring physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/ fatigue, emotional well-being, social functioning, pain, general health, and health change. Participants were asked to compare their current health to one year prior to their PAS pregnancy.

Results: Of the 448 respondents, the median age at delivery was 34 years (interquartile range (IQR) 31 – 37). Gestational age at delivery was 35 weeks (IQR 34-38). Participants were mostly white (89.5%), had private health insurance (69%), a history of depression (17.4%) and anxiety (23.4%). Surveys were completed at a median of 3 years (IQR 2–6) after PAS. Participants who had a hemorrhage vs. no hemorrhage reported lower QOL; specifically in social functioning, general health, and health change (all p</span>≤0.02). Peripartum hysterectomy vs. no hysterectomy was associated with a lower; specifically in energy/fatigue, emotional well-being, social functioning, and pain (all p≤0.04). Antenatal suspicion of PAS was associated with better QOL; specifically in role functioning/physical and pain (both p≤0.02). This pattern was not seen across all subscales between those who had an unplanned vs. planned delivery; however, those with unplanned delivery reported a better QOL in role functioning/physical and general health (both p=0.04).

Conclusion: Postpartum hemorrhage and hysterectomy resulting from a PAS pregnancy are associated with a lower QOL, even years after their delivery. Differences were also seen in those with and without an antenatal diagnosis, and those with unplanned vs. planned delivery.